Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT
A Pilot Study of Patients With Recurrent Glioblastoma Treated With Maximal Safe Neurosurgical Resection, Intra-Operative Radiation Therapy (IORT) Using the Xoft® Axxent® Electronic Brachytherapy System
Sponsor: Parkridge Medical Center
Terminated
No potential patients enrolled since first enrollment on 06/27/2022.
This NA trial investigates GBM and Glioblastoma and is currently terminated or withdrawn. Parkridge Medical Center leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Dec 2023 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Apr 2023 — Dec 2023 [monthly]
Recruiting NA
-
Apr 2021 — Apr 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Mar 2021 — Apr 2021 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Parkridge Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .